Cryder Capital Partners’s HCA Healthcare HCA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $195M | Buy |
499,017
+44,573
| +10% | +$18.8M | 12.26% | 4 |
|
|
2026
Q1 | $215M | Sell |
454,444
-75,701
| -14% | -$38.1M | 14.05% | 1 |
|
|
2025
Q4 | $248M | Sell |
530,145
-74,614
| -12% | -$34.6M | 14.62% | 2 |
|
|
2025
Q3 | $258M | Hold |
604,759
| – | – | 14.23% | 1 |
|
|
2025
Q2 | $232M | Buy |
604,759
+34,994
| +6% | +$12.6M | 13.04% | 2 |
|
|
2025
Q1 | $197M | Hold |
569,765
| – | – | 14.74% | 1 |
|
|
2024
Q4 | $171M | Sell |
569,765
-32,324
| -5% | -$11.3M | 12.44% | 3 |
|
|
2024
Q3 | $245M | Hold |
602,089
| – | – | 14.1% | 2 |
|
|
2024
Q2 | $193M | Sell |
602,089
-274,515
| -31% | -$89.2M | 12.12% | 4 |
|
|
2024
Q1 | $292M | Buy |
876,604
+35,547
| +4% | +$10.9M | 12.71% | 4 |
|
|
2023
Q4 | $228M | Sell |
841,057
-77,055
| -8% | -$19M | 11.27% | 6 |
|
|
2023
Q3 | $226M | Sell |
918,112
-2,871
| -0.3% | -$786K | 10.91% | 6 |
|
|
2023
Q2 | $279M | Sell |
920,983
-2,983
| -0.3% | -$829K | 13.63% | 2 |
|
|
2023
Q1 | $244M | Sell |
923,966
-8,563
| -0.9% | -$2.18M | 12.96% | 1 |
|
|
2022
Q4 | $224M | Sell |
932,529
-186,253
| -17% | -$41.7M | 13.84% | 1 |
|
|
2022
Q3 | $206M | Sell |
1,118,782
-1,360
| -0.1% | -$271K | 12.76% | 2 |
|
|
2022
Q2 | $188M | Buy |
1,120,142
+83,278
| +8% | +$17.9M | 10.28% | 6 |
|
|
2022
Q1 | $260M | Sell |
1,036,864
-84,855
| -8% | -$21.3M | 12.77% | 3 |
|
|
2021
Q4 | $288M | Hold |
1,121,719
| – | – | 13.05% | 2 |
|
|
2021
Q3 | $272M | Hold |
1,121,719
| – | – | 13.59% | 1 |
|
|
2021
Q2 | $232M | Buy |
1,121,719
+169,164
| +18% | +$34.5M | 12.05% | 4 |
|
|
2021
Q1 | $179M | Sell |
952,555
-22,856
| -2% | -$4.03M | 12.82% | 1 |
|
|
2020
Q4 | $160M | Buy |
975,411
+23,321
| +2% | +$3.41M | 12.81% | 1 |
|
|
2020
Q3 | $119M | Buy |
952,090
+144,607
| +18% | +$17.9M | 11.04% | 6 |
|
|
2020
Q2 | $78.4M | Hold |
807,483
| – | – | 8.49% | 7 |
|
|
2020
Q1 | $72.6M | Sell |
807,483
-89,270
| -10% | -$11.6M | 10.58% | 6 |
|
|
2019
Q4 | $133M | Hold |
896,753
| – | – | 15.03% | 1 |
|
|
2019
Q3 | $108M | Buy |
896,753
+81,226
| +10% | +$10.5M | 13.86% | 2 |
|
|
2019
Q2 | $110M | Buy |
815,527
+124,953
| +18% | +$15.8M | 16.31% | 3 |
|
|
2019
Q1 | $90M | Buy |
690,574
+5,392
| +0.8% | +$724K | 13.85% | 3 |
|
|
2018
Q4 | $85.3M | Sell |
685,182
-84,642
| -11% | -$11.4M | 15.52% | 3 |
|
|
2018
Q3 | $107M | Sell |
769,824
-65,832
| -8% | -$8.2M | 16.48% | 1 |
|
|
2018
Q2 | $85.7M | Buy |
835,656
+308,270
| +58% | +$31.2M | 14.01% | 2 |
|
|
2018
Q1 | $51.2M | Buy |
527,386
+19,980
| +4% | +$1.94M | 14.7% | 1 |
|
|
2017
Q4 | $44.6M | Buy |
507,406
+138,780
| +38% | +$11.1M | 14.36% | 2 |
|
|
2017
Q3 | $29.3M | Hold |
368,626
| – | – | 11.98% | 5 |
|
|
2017
Q2 | $37.5M | Hold |
368,626
| – | – | 13.75% | 1 |
|
|
2017
Q1 | $32.8M | Sell |
368,626
-13,020
| -3% | -$1.09M | 13.3% | 2 |
|
|
2016
Q4 | $28.2M | Buy |
381,646
+67,115
| +21% | +$5.03M | 12.61% | 2 |
|
|
2016
Q3 | $23.8M | Buy |
314,531
+76,630
| +32% | +$5.87M | 13.94% | 2 |
|
|
2016
Q2 | $18.3M | Buy |
237,901
+22,934
| +11% | +$1.81M | 14.7% | 2 |
|
|
2016
Q1 | $16.8M | Sell |
214,967
-6,336
| -3% | -$442K | 12.84% | 3 |
|
|
2015
Q4 | $15M | Buy |
221,303
+22,967
| +12% | +$1.6M | 12.57% | 3 |
|
|
2015
Q3 | $15.3M | Buy |
198,336
+30,240
| +18% | +$2.68M | 9.92% | 5 |
|
|
2015
Q2 | $15.2M | Buy |
+168,096
| New | +$13.5M | 11.06% | 1 |
|
Other funds holding HCA
CAM
MC
Cryder Capital Partners's HCA Position: Q2 2026 in Review
Cryder Capital Partners increased its HCA Healthcare (HCA) stake by 9.8% in Q2 2026, buying an estimated $18.8M and bringing the position to 499,017 shares worth $195M. The position accounts for 12.26% of the portfolio, ranked #4.
Cryder Capital Partners first reported a position in HCA in Q2 2015 and has held it in 45 quarters since. The position peaked at $292M in Q1 2024. 835 funds tracked by Wall St. Rank hold HCA as of Q2 2026.
- Cryder Capital Partners held 499,017 shares of HCA Healthcare worth $195M as of Q2 2026.
- Cryder Capital Partners bought 44,573 HCA Healthcare shares in Q2 2026, an estimated $18.8M.
- HCA Healthcare made up 12.26% of Cryder Capital Partners's portfolio in Q2 2026, its #4 holding.
- Cryder Capital Partners first reported a position in HCA Healthcare in Q2 2015 and has held it in 45 quarters since.
- Cryder Capital Partners's HCA Healthcare position peaked at $292M in Q1 2024.
- 835 funds tracked by Wall St. Rank held HCA Healthcare as of Q2 2026.
Based on Cryder Capital Partners's 13F filing for Q2 2026, filed 4 Aug 2026.